Disclosures for "Peripherally Administered Therapeutic One-armed Antibody Reversed Behavioral Abnormalities in a Marmoset Model of Anti-NMDAR Encephalitis"
-
Dr. Matsumoto has received personal compensation for serving as an employee of Arialys Therapeutics, Inc.. Dr. Matsumoto has received personal compensation for serving as an employee of Astellas Pharma Inc.. Dr. Matsumoto has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Arialys Therapeutics, Inc.. Dr. Matsumoto has stock in Arialys Therapeutics, Inc.. Dr. Matsumoto has received intellectual property interests from a discovery or technology relating to health care. Dr. Matsumoto has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Maeda has received personal compensation for serving as an employee of Astellas Pharma Inc.. Dr. Maeda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arialys Therapeytic Inc.. Dr. Maeda has received intellectual property interests from a discovery or technology relating to health care.
-
Mr. Kanno has received personal compensation for serving as an employee of Astellas Pharma Inc,. Mr. Kanno has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arialys. Mr. Kanno has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Kubo has received personal compensation for serving as an employee of Astellas Pharma Inc.. Dr. Kubo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arialys Therapeutics Inc.. Dr. Kubo has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Yamaki has received personal compensation for serving as an employee of Arialys. Dr. Yamaki has received personal compensation for serving as an employee of Astellas. Dr. Yamaki has received intellectual property interests from a discovery or technology relating to health care.
-
Mrs. Kazimi has received personal compensation for serving as an employee of Arialys Therapeutics. Mrs. Kazimi has received personal compensation for serving as an employee of BPS Bioscience.
-
Dr. Razai has received personal compensation for serving as an employee of Arialys . Dr. Razai has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aivocode inc . Dr. Razai has stock in Inhibrx . Dr. Razai has received intellectual property interests from a discovery or technology relating to health care.
-
Ms. Eastman has nothing to disclose.
-
Mr. Mitchell has received personal compensation for serving as an employee of Arialys Therapeutics.
-
-
Dr. Lichter has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Janux.